Figure 8 Investment Strategies LLC Makes New $685,000 Investment in Versigent $VGNT

Figure 8 Investment Strategies LLC purchased a new stake in shares of Versigent (NYSE:VGNTFree Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 16,305 shares of the company’s stock, valued at approximately $685,000.

Other large investors have also made changes to their positions in the company. Wellington Management Group LLP bought a new position in shares of Versigent in the second quarter worth about $940,000. Ancora Advisors LLC bought a new stake in Versigent during the 2nd quarter valued at approximately $4,197,000. Kintegral Advisory LLC purchased a new position in Versigent in the 2nd quarter worth approximately $224,000. Nan Shan Life Insurance Co. Ltd. purchased a new position in Versigent in the 2nd quarter worth approximately $5,400,000. Finally, Raiffeisen Bank International AG purchased a new position in Versigent in the 2nd quarter worth approximately $1,182,000.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on VGNT shares. TD Cowen increased their price objective on shares of Versigent from $49.00 to $58.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Fox Advisors downgraded shares of Versigent from an “overweight” rating to an “equal weight” rating in a report on Wednesday, August 5th. UBS Group dropped their target price on shares of Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, July 9th. Evercore reaffirmed an “outperform” rating and set a $65.00 target price on shares of Versigent in a research note on Monday, August 10th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $59.00 price target on shares of Versigent in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Versigent presently has an average rating of “Moderate Buy” and an average price target of $54.00.

View Our Latest Stock Analysis on VGNT

Versigent Trading Up 3.7%

Shares of Versigent stock opened at $50.21 on Friday. The company’s 50 day moving average price is $43.75. Versigent has a 12 month low of $26.34 and a 12 month high of $50.88. The company has a market capitalization of $3.56 billion and a price-to-earnings ratio of 26.15. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNTGet Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.29 billion. As a group, equities research analysts forecast that Versigent will post 7.23 earnings per share for the current fiscal year.

Versigent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be issued a $0.13 dividend. The ex-dividend date of this dividend is Friday, September 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.0%.

Versigent Profile

(Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

See Also

Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNTFree Report).

Institutional Ownership by Quarter for Versigent (NYSE:VGNT)

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.